326
Views
19
CrossRef citations to date
0
Altmetric
Review

New Perspectives in the Diagnosis and Management of Allergic Fungal Airway Disease

ORCID Icon, , , , ORCID Icon & ORCID Icon
Pages 557-573 | Published online: 25 May 2021

References

  • Denning DW, O’Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J. 2006;27(3):615–626. doi:10.1183/09031936.06.00074705
  • Denning DW, Pashley C, Hartl D, et al. Fungal allergy in asthma-state of the art and research needs. Clin Transl Allerg. 2014;4:14. doi:10.1186/2045-7022-4-14
  • Knutsen AP, Bush RK, Demain JG, et al. Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol. 2012;129(2):280–283. doi:10.1016/j.jaci.2011.12.970
  • Wardlaw AJ, Woolnough K, Pashley CH. Lassoing a chimera: the semantics of allergic fungal airway disease. Clin Exp Allergy. 2015;45(12):1746–1749. doi:10.1111/cea.12659
  • Ozyigit LP, Monteiro W, Rick EM, Satchwell J, Pashley CH, Wardlaw AJ. Fungal bronchitis is a distinct clinical entity which is responsive to antifungal therapy. Chronic Respir Dis. 2021;18:1479973120964448. doi:10.1177/1479973120964448
  • Pavord ID, Wardlaw AJ. The A to E of airway disease. Clin Exp Allergy. 2010;40(1):62–67. doi:10.1111/j.1365-2222.2009.03410.x
  • Wardlaw AJ, Silverman M, Siva R, Pavord ID, Green R. Multi-dimensional phenotyping: towards a new taxonomy for airway disease. Clin Exp Allergy. 2005;35(10):1254–1262. doi:10.1111/j.1365-2222.2005.02344.x
  • Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178(3):218–224. doi:10.1164/rccm.200711-1754OC
  • Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008;372(9643):1107–1119. doi:10.1016/S0140-6736(08)61452-X
  • Rosenberg M, Patterson R, Mintzer R, Cooper BJ, Roberts M, Harris KE. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med. 1977;86(4):405–414. doi:10.7326/0003-4819-86-4-405
  • Hinson KF, Moon AJ, Plummer NS. Broncho-pulmonary aspergillosis; a review and a report of eight new cases. Thorax. 1952;7(4):317–333. doi:10.1136/thx.7.4.317
  • Greenberger PA, Bush RK, Demain JG, Luong A, Slavin RG, Knutsen AP. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol Pract. 2014;2(6):703–708. doi:10.1016/j.jaip.2014.08.007
  • Agarwal R, Maskey D, Aggarwal AN, et al. Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis. PLoS One. 2013;8(4):e61105. doi:10.1371/journal.pone.0061105
  • Asano K, Hebisawa A, Ishiguro T, et al. New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation. J Allergy Clin Immunol. 2020;147:1261–1268.e5. doi:10.1016/j.jaci.2020.08.029
  • Li E, Landers CT, Tung HY, et al. Fungi in mucoobstructive airway diseases. Ann Am Thorac Soc. 2018;15(Suppl 3):S198–S204. doi:10.1513/AnnalsATS.201803-154AW
  • Tiew PY, Ko FWS, Pang SL, et al. Environmental fungal sensitisation associates with poorer clinical outcomes in COPD. Eur Respir J. 2020;56(2):2000418. doi:10.1183/13993003.00418-2020
  • Bafadhel M, McKenna S, Agbetile J, et al. Aspergillus fumigatus during stable state and exacerbations of COPD. Eur Respir J. 2013;43:64–71. doi:10.1183/09031936.00162912
  • Everaerts S, Lagrou K, Dubbeldam A, et al. Sensitization to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:2629–2638. doi:10.2147/COPD.S141695
  • Sehgal IS, Dhooria S, Prasad KT, et al. Sensitization to A fumigatus in subjects with non-cystic fibrosis bronchiectasis. Mycoses. 2020.
  • Woolnough KF, Richardson M, Newby C, et al. The relationship between biomarkers of fungal allergy and lung damage in asthma. Clin Exp Allergy. 2017;47(1):48–56. doi:10.1111/cea.12848
  • Denning DW, O’Driscoll BR, Powell G, et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: the Fungal Asthma Sensitization Trial (FAST) study. Am J Respir Crit Care Med. 2009;179(1):11–18. doi:10.1164/rccm.200805-737OC
  • Wark P, Hussaini S, Holder C, Powell H, Gibson P, Oldmeadow C. Omalizumab is an effective intervention in severe asthma with fungal sensitization. J Allergy Clin Immunol Pract. 2020;8(10):3428–33 e1. doi:10.1016/j.jaip.2020.05.055
  • Blakey JD, Wardlaw AJ. What is severe asthma? Clin Exp Allergy. 2012;42(5):617–624. doi:10.1111/j.1365-2222.2012.03962.x
  • Lotvall J, Akdis CA, Bacharier LB, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol. 2011;127(2):355–360. doi:10.1016/j.jaci.2010.11.037
  • Tyler MA, Luong AU. Current concepts in the management of allergic fungal rhinosinusitis. Immunol Allergy Clin North Am. 2020;40(2):345–359. doi:10.1016/j.iac.2019.12.001
  • Bent JP, Kuhn FA. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg. 1994;111(5):580–588. doi:10.1177/019459989411100508
  • Hawksworth DL, Lucking R. Fungal diversity revisited: 2.2 to 3.8 million species. Microbiol Spectr. 2017;5(4). doi:10.1128/microbiolspec.FUNK-0052-2016
  • Pashley CH, Fairs A, Free RC, Wardlaw AJ. DNA analysis of outdoor air reveals a high degree of fungal diversity, temporal variability, and genera not seen by spore morphology. Fungal Biol. 2012;116(2):214–224. doi:10.1016/j.funbio.2011.11.004
  • Simon-Nobbe B, Denk U, Poll V, Rid R, Breitenbach M. The spectrum of fungal allergy. Int Arch Allergy Immunol. 2008;145(1):58–86. doi:10.1159/000107578
  • Crameri R, Garbani M, Rhyner C, Huitema C. Fungi: the neglected allergenic sources. Allergy. 2014;69(2):176–185. doi:10.1111/all.12325
  • Pedrosa AF, Lisboa C, Rodrigues AG. Malassezia infections with systemic involvement: figures and facts. J Dermatol. 2018;45(11):1278–1282. doi:10.1111/1346-8138.14653
  • Petrucelli MF, Abreu MH, Cantelli BAM, et al. Epidemiology and diagnostic perspectives of dermatophytoses. J Fungi (Basel). 2020;6(4). doi:10.3390/jof6040310.
  • Woodfolk JA. Allergy and dermatophytes. Clin Microbiol Rev. 2005;18(1):30–43. doi:10.1128/CMR.18.1.30-43.2005
  • Adav SS, Ravindran A, Sze SK. Proteomic analysis of temperature dependent extracellular proteins from Aspergillus fumigatus grown under solid-state culture condition. J Proteome Res. 2013;12(6):2715–2731. doi:10.1021/pr4000762
  • Douglas P, Tyrrel SF, Kinnersley RP, et al. Predicting Aspergillus fumigatus exposure from composting facilities using a dispersion model: a conditional calibration and validation. Int J Hyg Environ Health. 2017;220(1):17–28. doi:10.1016/j.ijheh.2016.09.017
  • Fairs A, Wardlaw AJ, Thompson JR, Pashley CH. Guidelines on ambient intramural airborne fungal spores. J Investig Allergol Clin Immunol. 2010;20(6):490–498.
  • Andersen B, Frisvad JC, Sondergaard I, Rasmussen IS, Larsen LS. Associations between fungal species and water-damaged building materials. Appl Environ Microbiol. 2011;77(12):4180–4188. doi:10.1128/AEM.02513-10
  • Aimanianda V, Latge JP. Fungal hydrophobins form a sheath preventing immune recognition of airborne conidia. Virulence. 2010;1(3):185–187. doi:10.4161/viru.1.3.11317
  • Barnes C. Fungi and atopy. Clin Rev Allergy Immunol. 2019;57(3):439–448. doi:10.1007/s12016-019-08750-z
  • Douwes J, Thorne P, Pearce N, Heederik D. Bioaerosol health effects and exposure assessment: progress and prospects. Ann Occup Hyg. 2003;47(3):187–200. doi:10.1093/annhyg/meg032
  • Quirce S, Vandenplas O, Campo P, et al. Occupational hypersensitivity pneumonitis: an EAACI position paper. Allergy. 2016;71(6):765–779. doi:10.1111/all.12866
  • Barbeau DN, Grimsley LF, White LE, El-Dahr JM, Lichtveld M. Mold exposure and health effects following hurricanes Katrina and Rita. Annu Rev Public Health. 2010;31:165–78 1 p following 78. doi:10.1146/annurev.publhealth.012809.103643
  • Oluyomi AO, Panthagani K, Sotelo J, et al. Houston hurricane Harvey health (Houston-3H) study: assessment of allergic symptoms and stress after hurricane Harvey flooding. Environ Health. 2021;20(1):9. doi:10.1186/s12940-021-00694-2
  • Tischer C, Chen CM, Heinrich J. Association between domestic mould and mould components, and asthma and allergy in children: a systematic review. Eur Respir J. 2011;38(4):812–824. doi:10.1183/09031936.00184010
  • Fukutomi Y, Taniguchi M. Sensitization to fungal allergens: resolved and unresolved issues. Allergol Int. 2015;64(4):321–331. doi:10.1016/j.alit.2015.05.007
  • Goodman RE, Chapman MD, Slater JE. The allergen: sources, extracts, and molecules for diagnosis of allergic disease. J Allergy Clin Immunol Pract. 2020;8(8):2506–2514. doi:10.1016/j.jaip.2020.06.043
  • Fukutomi Y, Tanimoto H, Yasueda H, Taniguchi M. Serological diagnosis of allergic bronchopulmonary mycosis: progress and challenges. Allergol Int. 2016;65(1):30–36. doi:10.1016/j.alit.2015.08.004
  • Crameri R. The problem of cross-reactivity in the diagnosis of fungal allergy. Clin Exp Allergy. 2011;41(3):302–304. doi:10.1111/j.1365-2222.2011.03703.x
  • Woolnough K, Craner M, Pashley CH, Wardlaw AJ. rAsp f3 and rAsp f4 are associated with bronchiectasis in allergic fungal airways disease. Ann Allergy Asthma Immunol. 2018;120(3):325–326. doi:10.1016/j.anai.2017.10.026
  • Database WA. Allergen Nomenclature; 2020. Available from: http://www.allergen.org/search.php?allergensource=Aspergillus+fumigatus. Accessed May 10, 2021.
  • Tanimoto H, Fukutomi Y, Yasueda H, et al. Molecular-based allergy diagnosis of allergic bronchopulmonary aspergillosis in Aspergillus fumigatus-sensitized Japanese patients. Clin Exp Allergy. 2015;45(12):1790–1800. doi:10.1111/cea.12590
  • Muthu V, Sehgal IS, Dhooria S, Aggarwal AN, Agarwal R. Utility of recombinant Aspergillus fumigatus antigens in the diagnosis of allergic bronchopulmonary aspergillosis: a systematic review and diagnostic test accuracy meta-analysis. Clin Exp Allergy. 2018;48(9):1107–1136. doi:10.1111/cea.13216
  • Russell RJ, Brightling C. Pathogenesis of asthma: implications for precision medicine. Clin Sci (Lond). 2017;131(14):1723–1735. doi:10.1042/CS20160253
  • Boonpiyathad T, Sozener ZC, Satitsuksanoa P, Akdis CA. Immunologic mechanisms in asthma. Semin Immunol. 2019;46:101333. doi:10.1016/j.smim.2019.101333
  • Mackel JJ, Steele C. Host defense mechanisms against Aspergillus fumigatus lung colonization and invasion. Curr Opin Microbiol. 2019;52:14–19.
  • Bacher P, Hohnstein T, Beerbaum E, et al. Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against Candida albicans. Cell. 2019;176(6):1340–55 e15. doi:10.1016/j.cell.2019.01.041
  • Choy DF, Hart KM, Borthwick LA, et al. TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma. Sci Transl Med. 2015;7(301):301ra129. doi:10.1126/scitranslmed.aab3142
  • Siddiqui S, Shikotra A, Richardson M, et al. Airway pathological heterogeneity in asthma: visualization of disease microclusters using topological data analysis. J Allergy Clin Immunol. 2018;142(5):1457–1468. doi:10.1016/j.jaci.2017.12.982
  • Ueki S, Hebisawa A, Kitani M, Asano K, Neves JS. Allergic bronchopulmonary aspergillosis-A luminal hypereosinophilic disease with extracellular trap cell death. Front Immunol. 2018;9:2346. doi:10.3389/fimmu.2018.02346
  • Yike I. Fungal proteases and their pathophysiological effects. Mycopathologia. 2011;171(5):299–323. doi:10.1007/s11046-010-9386-2
  • Wartenberg D, Lapp K, Jacobsen ID, et al. Secretome analysis of Aspergillus fumigatus reveals Asp-hemolysin as a major secreted protein. Int J Med Microbiol. 2011;301(7):602–611. doi:10.1016/j.ijmm.2011.04.016
  • Druey KM, McCullough M, Krishnan R. Aspergillus fumigatus protease alkaline protease 1 (Alp1): a new therapeutic target for fungal asthma. J Fungi (Basel). 2020;6(2). doi:10.3390/jof6020088
  • Wiesner DL, Merkhofer RM, Ober C, et al. Club cell TRPV4 serves as a damage sensor driving lung allergic inflammation. Cell Host Microbe. 2020;27(4):614–28 e6. doi:10.1016/j.chom.2020.02.006
  • Balenga NA, Klichinsky M, Xie Z, et al. A fungal protease allergen provokes airway hyper-responsiveness in asthma. Nat Commun. 2015;6:6763. doi:10.1038/ncomms7763
  • Basu T, Seyedmousavi S, Sugui JA, et al. Aspergillus fumigatus alkaline protease 1 (Alp1/Asp f13) in the airways correlates with asthma severity. J Allergy Clin Immunol. 2018;141(1):423–5 e7. doi:10.1016/j.jaci.2017.07.034
  • Agarwal R, Khan A, Gupta D, Aggarwal AN, Saxena AK, Chakrabarti A. An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus. PLoS One. 2010;5(12):e15346. doi:10.1371/journal.pone.0015346
  • Lu HW, Mao B, Wei P, et al. The clinical characteristics and prognosis of ABPA are closely related to the mucus plugs in central bronchiectasis. Clin Respir J. 2020;14(2):140–147. doi:10.1111/crj.13111
  • Bonser LR, Erle DJ. Airway mucus and asthma: the role of MUC5AC and MUC5B. J Clin Med. 2017;6(12):112. doi:10.3390/jcm6120112
  • Dunican EM, Watchorn DC, Fahy JV. Autopsy and imaging studies of mucus in asthma. Lessons learned about disease mechanisms and the role of mucus in airflow obstruction. Ann Am Thorac Soc. 2018;15(Suppl 3):S184–S91. doi:10.1513/AnnalsATS.201807-485AW
  • Dunican EM, Elicker BM, Gierada DS, et al. Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction. J Clin Invest. 2018;128(3):997–1009. doi:10.1172/JCI95693
  • Dournes G, Berger P, Refait J, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis: MR imaging of airway mucus contrasts as a tool for diagnosis. Radiology. 2017;285(1):261–269. doi:10.1148/radiol.2017162350
  • Boyton RJ, Altmann DM. Bronchiectasis: current concepts in pathogenesis, immunology, and microbiology. Annu Rev Pathol. 2016;11:523–554. doi:10.1146/annurev-pathol-012615-044344
  • Bush A, Floto RA. Pathophysiology, causes and genetics of paediatric and adult bronchiectasis. Respirology. 2019;24(11):1053–1062. doi:10.1111/resp.13509
  • Cole PJ. Inflammation: a two-edged sword–the model of bronchiectasis. Eur J Respir Dis Suppl. 1986;147:6–15.
  • Li E, Knight JM, Wu Y, et al. Airway mycosis in allergic airway disease. Adv Immunol. 2019;142:85–140.
  • Burgel PR, Lazarus SC, Tam DC, et al. Human eosinophils induce mucin production in airway epithelial cells via epidermal growth factor receptor activation. J Immunol. 2001;167(10):5948–5954. doi:10.4049/jimmunol.167.10.5948
  • Persson EK, Verstraete K, Heyndrickx I, et al. Protein crystallization promotes type 2 immunity and is reversible by antibody treatment. Science. 2019;364:6442. doi:10.1126/science.aaw4295
  • Muniz VS, Silva JC, Braga YAV, et al. Eosinophils release extracellular DNA traps in response to Aspergillus fumigatus. J Allergy Clin Immunol. 2018;141(2):571–85 e7. doi:10.1016/j.jaci.2017.07.048
  • Figueiredo RT, Neves JS. Eosinophils in fungal diseases: an overview. J Leukoc Biol. 2018;104(1):49–60. doi:10.1002/JLB.4MR1117-473R
  • Wardlaw A, Howarth PH, Israel E, et al. Fungal sensitization and its relationship to mepolizumab response in patients with severe eosinophilic asthma. Clin Exp Allergy. 2020;50(7):869–872. doi:10.1111/cea.13680
  • Fabbri LM, Romagnoli M, Corbetta L, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167(3):418–424. doi:10.1164/rccm.200203-183OC
  • Hirahara K, Aoki A, Morimoto Y, Kiuchi M, Okano M, Nakayama T. The immunopathology of lung fibrosis: amphiregulin-producing pathogenic memory T helper-2 cells control the airway fibrotic responses by inducing eosinophils to secrete osteopontin. Semin Immunopathol. 2019;41(3):339–348. doi:10.1007/s00281-019-00735-6
  • Nhu QM, Aceves SS. Tissue remodeling in chronic eosinophilic esophageal inflammation: parallels in asthma and therapeutic perspectives. Front Med (Lausanne). 2017;4:128. doi:10.3389/fmed.2017.00128
  • Gieseck RL, Wilson MS, Wynn TA. Type 2 immunity in tissue repair and fibrosis. Nat Rev Immunol. 2018;18(1):62–76.
  • Bartemes KR, Kita H. Innate and adaptive immune responses to fungi in the airway. J Allergy Clin Immunol. 2018;142(2):353–363. doi:10.1016/j.jaci.2018.06.015
  • Chauhan B, Hutcheson PS, Slavin RG, Bellone CJ. MHC restriction in allergic bronchopulmonary aspergillosis. Front Biosci. 2003;8:s140–8. doi:10.2741/971
  • Agarwal R, Chakrabarti A, Shah A, et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy. 2013;43(8):850–873.
  • Pashley CH, Fairs A, Morley JP, et al. Routine processing procedures for isolating filamentous fungi from respiratory sputum samples may underestimate fungal prevalence. Med Mycol. 2012;50(4):433–438. doi:10.3109/13693786.2011.615762
  • Vergidis P, Moore CB, Novak-Frazer L, et al. High-volume culture and quantitative real-time PCR for the detection of Aspergillus in sputum. Clin Microbiol Infect. 2020;26(7):935–940. doi:10.1016/j.cmi.2019.11.019
  • Pappas PG, Kauffman CA, Andes DR, et al. Executive summary: clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):409–417. doi:10.1093/cid/civ1194
  • Agbetile J, Fairs A, Desai D, et al. Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1. Clin Exp Allergy. 2012;42(5):782–791. doi:10.1111/j.1365-2222.2012.03987.x
  • Farrant J, Brice H, Fowler S, Niven R. Fungal sensitisation in severe asthma is associated with the identification of Aspergillus fumigatus in sputum. J Asthma. 2016;53(7):732–735. doi:10.3109/02770903.2016.1154073
  • Scadding AJ, Pashley CH, Monteiro W, Bhatt H, Wardlaw AJ. Cultural fungal mycobiome in non-cystic bronchiectasis. Thorax. 2018;73(Suppl 4):P8.
  • Fraczek MG, Kirwan MB, Moore CB, Morris J, Denning DW, Richardson MD. Volume dependency for culture of fungi from respiratory secretions and increased sensitivity of Aspergillus quantitative PCR. Mycoses. 2014;57(2):69–78. doi:10.1111/myc.12103
  • Fayemiwo S, Moore CB, Foden P, Denning DW, Richardson MD. Comparative performance of Aspergillus galactomannan ELISA and PCR in sputum from patients with ABPA and CPA. J Microbiol Methods. 2017;140:32–39. doi:10.1016/j.mimet.2017.06.016
  • Rick EM, Woolnough KF, Seear PJ, et al. The airway fungal microbiome in asthma. Clin Exp Allergy. 2020;50(12):1325–1341. doi:10.1111/cea.13722
  • Sullivan A, Hunt EB, Ward C, et al. The presence of Aspergillus fumigatus in asthmatic airways is not clearly related to clinical disease severity. Allergy. 2020;75(5):1146–1154. doi:10.1111/all.14087
  • Gautier M, Normand AC, L’Ollivier C, et al. Aspergillus tubingensis: a major filamentous fungus found in the airways of patients with lung disease. Med Mycol. 2016;54(5):459–470. doi:10.1093/mmy/myv118
  • D’Hooge E, Becker P, Stubbe D, Normand AC, Piarroux R, Hendrickx M. Black aspergilli: a remaining challenge in fungal taxonomy? Med Mycol. 2019;57(6):773–780. doi:10.1093/mmy/myy124
  • Gago S, Overton NLD, Ben-Ghazzi N, et al. Lung colonization by Aspergillus fumigatus is controlled by ZNF77. Nat Commun. 2018;9(1):3835. doi:10.1038/s41467-018-06148-7
  • Fraczek MG, Chishimba L, Niven RM, et al. Corticosteroid treatment is associated with increased filamentous fungal burden in allergic fungal disease. J Allergy Clin Immunol. 2018;142(2):407–414. doi:10.1016/j.jaci.2017.09.039
  • Gago S, Denning DW, Bowyer P. Pathophysiological aspects of Aspergillus colonization in disease. Med Mycol. 2019;57(Supplement_2):S219–S27. doi:10.1093/mmy/myy076
  • Li BC, Huh SM, Prieto MD, et al. Biomarkers for the diagnosis of allergic bronchopulmonary aspergillosis in cystic fibrosis: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2021;9. doi:10.1016/j.jaip.2020.12.064
  • O’Driscoll BR, Powell G, Chew F, et al. Comparison of skin prick tests with specific serum immunoglobulin E in the diagnosis of fungal sensitization in patients with severe asthma. Clin Exp Allergy. 2009;39(11):1677–1683. doi:10.1111/j.1365-2222.2009.03339.x
  • O’Driscoll BR, Hopkinson LC, Denning DW. Mold sensitization is common amongst patients with severe asthma requiring multiple hospital admissions. BMC Pulm Med. 2005;5:4. doi:10.1186/1471-2466-5-4
  • Fairs A, Agbetile J, Hargadon B, et al. IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma. Am J Respir Crit Care Med. 2010;182(11):1362–1368. doi:10.1164/rccm.201001-0087OC
  • Menzies D, Holmes L, McCumesky G, Prys-Picard C, Niven R. Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma. Allergy. 2011;66(5):679–685. doi:10.1111/j.1398-9995.2010.02542.x
  • Agarwal R, Gupta D, Aggarwal AN, Saxena AK, Chakrabarti A, Jindal SK. Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients. Chest. 2007;132(4):1183–1190. doi:10.1378/chest.07-0808
  • Kaur M, Sudan DS. Allergic Bronchopulmonary Aspergillosis (ABPA)-the High Resolution Computed Tomography (HRCT) chest imaging scenario. J Clin Diagn Res. 2014;8(6):RC05–7. doi:10.7860/JCDR/2014/8255.4423
  • Refait J, Macey J, Bui S, et al. CT evaluation of hyperattenuating mucus to diagnose allergic bronchopulmonary aspergillosis in the special condition of cystic fibrosis. J Cyst Fibros. 2019;18(4):e31–e6. doi:10.1016/j.jcf.2019.02.002
  • Horn BR, Robin ED, Theodore J, Van-kessel A. Total eosinophil counts in the management of bronchial asthma. N Engl J Med. 1975;292:1152–1155. doi:10.1056/NEJM197505292922204
  • Goh KJ, Yii ACA, Lapperre TS, et al. Sensitization to Aspergillus species is associated with frequent exacerbations in severe asthma. J Asthma Allergy. 2017;10:131–140. doi:10.2147/JAA.S130459
  • Maturu VN, Agarwal R. Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis. Clin Exp Allergy. 2015;45(12):1765–1778. doi:10.1111/cea.12595
  • Baxter CG, Moore CB, Jones AM, Webb AK, Denning DW. IgE-mediated immune responses and airway detection of Aspergillus and Candida in adult cystic fibrosis. Chest. 2013;143(5):1351–1357. doi:10.1378/chest.12-1363
  • Pacheco A, Cuevas M, Carbelo B, et al. Eosinophilic lung disease associated with Candida albicans allergy. Eur Respir J. 1998;12(2):502–504. doi:10.1183/09031936.98.12020502
  • Bain GA, Flower CD. Pulmonary eosinophilia. Eur J Radiol. 1996;23(1):3–8. doi:10.1016/0720-048X(96)01029-7
  • Sanchez-Alarcos JM, Martinez-Cruz R, Ortega L, Calle M, Rodriguez-Hermosa JL, Alvarez-Sala JL. ABPA mimicking bronchogenic cancer. Allergy. 2001;56(1):80–81. doi:10.1034/j.1398-9995.2001.00840.x
  • Wardlaw AJ, Wharin S, Aung H, Shaffu S, Siddiqui S. The causes of a peripheral blood eosinophilia in a secondary care setting. Clin Exp Allerg. 2021;In Press.
  • Kirschner AN, Kuhlmann E, Kuzniar TJ. Eosinophilic pleural effusion complicating allergic bronchopulmonary aspergillosis. Respiration. 2011;82(5):478–481. doi:10.1159/000323617
  • Wark P, Wilson AW, Gibson PG. Azoles for allergic bronchopulmonary aspergillosis. Cochrane Database Syst Rev. 2000;(3):CD001108.
  • Liao Q, Lam KW. Inhaled antifungal agents for the treatment and prophylaxis of pulmonary mycoses. Curr Pharm Des. 2021;26. doi:10.2174/1381612826666210101153547
  • Murray A, Cass L, Ito K, et al. PC945, a novel inhaled antifungal agent, for the treatment of respiratory fungal infections. J Fungi (Basel). 2020;6(4). doi:10.3390/jof6040373.
  • Agbetile J, Bourne M, Fairs A, et al. Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study). J Allergy Clin Immunol. 2014;134(1):33–39. doi:10.1016/j.jaci.2013.09.050
  • Wark PA, Hensley MJ, Saltos N, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol. 2003;111(5):952–957. doi:10.1067/mai.2003.1388
  • Stevens DA, Schwartz HJ, Lee JY, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med. 2000;342(11):756–762. doi:10.1056/NEJM200003163421102
  • Chishimba L, Niven RM, Cooley J, Denning DW. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. J Asthma. 2012;49(4):423–433. doi:10.3109/02770903.2012.662568
  • Rapeport WG, Ito K, Denning DW. The role of antifungals in the management of patients with severe asthma. Clin Transl Allerg. 2020;10(1):46. doi:10.1186/s13601-020-00353-8
  • Brandt C, Roehmel J, Rickerts V, Melichar V, Niemann N, Schwarz C. Aspergillus bronchitis in patients with cystic fibrosis. Mycopathologia. 2018;183(1):61–69. doi:10.1007/s11046-017-0190-0
  • Johnson DC. Chronic candidal bronchitis: a consecutive series. Open Respir Med J. 2012;6:145–149. doi:10.2174/1874306401206010145
  • Manti S, Fabio Parisi G, Papale M, et al. Allergic bronchopulmonary aspergillosis in children. Pediatr Allergy Immunol. 2020;31(Suppl 26):20–22. doi:10.1111/pai.13357
  • Sunman B, Ademhan Tural D, Ozsezen B, Emiralioglu N, Yalcin E, Ozcelik U. Current approach in the diagnosis and management of allergic bronchopulmonary aspergillosis in children with cystic fibrosis. Front Pediatr. 2020;8:582964. doi:10.3389/fped.2020.582964
  • Bush A. Kids, difficult asthma and fungus. J Fungi (Basel). 2020;6(2). doi:10.3390/jof6020055
  • Castanhinha S, Sherburn R, Walker S, et al. Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33. J Allergy Clin Immunol. 2015;136(2):312–22 e7. doi:10.1016/j.jaci.2015.01.016
  • Welsh KG, Holden KA, Wardlaw AJ, et al. Fungal sensitization and positive fungal culture from sputum in children with asthma are associated with reduced lung function and acute asthma attacks respectively. Clin Exp Allergy. 2020. doi:10.1111/cea.13799